Unichem subsidiary should grow by around 22 ... 180-day marketing exclusivity in gPred-forte and the launch of Rivaroxaban tablets. Emerging and RoW markets are expected to grow 11 per cent ...

Here’s how it works. This future third-generation tablet will drop in 2027 with the upgraded Tensor G6 chip that has previously been rumored to be built on a 3nm node. Apparently, Google will ...

Mumbai: Unichem Laboratories Limited has announced that the Company has received Abbreviated New Drug Application (ANDA) approval for its Doxazosin Tablets USP, 1 mg, 2 mg, 4 mg and 8 mg from the ...

Ipca, which makes paracetamol tablets under the brand name Pacimol, will also launch an open offer to Unichem's shareholders to buy an additional 26% stake for 8.05 billion rupees, according to a ...

BENGALURU (Reuters) – Indian pharmaceutical firm Ipca Laboratories Ltd said on Monday it has agreed to buy a 33.38% stake in Unichem Laboratories Ltd for up to 10.34 billion rupees ($126.26 million).

Ipca, which makes paracetamol tablets under the brand name Pacimol, is also launching an open offer to Unichem's shareholders to buy an additional 26% stake for 8.05 billion rupees, it said in a ...

New Delhi, Oct 5: Unichem Pharmaceuticals USA Inc is recalling 18,960 bottles of the hypertension treatment medication Clonidine Hydrochloride tablets in the American market for product mix-up, ...

Unichem Laboratories has received ANDA approval for its Quetiapine Extended-Release Tablets USP, 50 mg, 150 mg, 200 mg, 300 mg, and 400 mg from the United States Food and Drug Administration ...

Unichem Laboratories Limited has received ANDA approval for its Quetiapine Extended-Release Tablets USP, 50 mg, 150 mg, 200 mg, 300 mg, and 400 mg from the United States Food and Drug ...

New Delhi, Mar 16 (PTI) Unichem Laboratories on Wednesday said it has received approval from the US health regulator to market its generic version of Nebivolol tablets indicated for the treatment ...

Unichem Laboratories on Wednesday said it has received approval from the US health regulator to market its generic version of Nebivolol tablets indicated for the treatment of hypertension. The ...